960 results on '"Laskin J"'
Search Results
2. Molecular composition of particulate matter emissions from dung and brushwood burning household cookstoves in Haryana, India
3. Effect of relative humidity on the composition of secondary organic aerosol from the oxidation of toluene
4. Nitro-oleic Acid Mitigates Chlorine-induced Lung Injury in Mice by Inhibiting Pro-inflammatory Macrophage Activation
5. Molecular Diversity of Sea Spray Aerosol Particles: Impact of Ocean Biology on Particle Composition and Hygroscopicity
6. NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents
7. Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
8. A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies
9. Complex refractive indices in the near-ultraviolet spectral region of biogenic secondary organic aerosol aged with ammonia
10. Effect of humidity on the composition of isoprene photooxidation secondary organic aerosol
11. Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
12. Association between walking 5000 step/day and fall incidence over six months in urban community-dwelling older people
13. Impaired Lung Functioning Following Chronic Ozone Exposure Is Associated With Inflammatory Macrophage Activation and Altered Bioenergetics
14. Proinflammatory Activation of Lung Macrophages and Altered Bioenergetics Following Chlorine Inhalation in Mice
15. Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study
16. Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
17. Evaluation of a ‘Watch and Wait’ Approach for Chemotherapy in Patients with Newly Diagnosed Advanced Non-small Cell Lung Cancer from a Diverse Community Population
18. Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment
19. LBA4 Preliminary safety and efficacy of adagrasib with pembrolizumab in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation
20. 1110P Clinical outcomes for EGFR/HER2 exon 20 insertion-mutated NSCLC
21. 964P PACIFIC on the West Coast: Exploring reasons for not receiving consolidative durvalumab in the treatment of locally advanced lung cancer
22. EP04.02-004 The Patient Impact of Liquid Biopsy - Health-Related Quality of Life in Patients Undergoing Liquid Biopsy for Advanced Non-Small Cell Lung Cancer
23. EP08.02-108 Osimertinib Long-Term Tolerability in Patients with EGFRm NSCLC Enrolled in the AURA Program or FLAURA Study
24. 960P Beyond PACIFIC: Real-world outcomes of adjuvant durvalumab according to treatment received and PD-L1 expression
25. EP.08F.12 Toxicity and Outcomes by Radio-Sensitizing Chemotherapy Regimen for Unresectable Stage III NSCLC in British Columbia, Canada
26. 87P Application of tissue and liquid-based next generation sequencing (NGS) for comprehensive genomic profiling: Evaluating the clinical value of ctDNA technology in treatment decision making
27. Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer
28. HPR129 Real-World Policy Effects of Implementing Multi-Gene Panel Sequencing for Advanced Cancers in British Columbia, Canada: An Interrupted Time Series Analysis
29. Nitrogen Mustard Exposure Is Associated with Impaired Bioenergetics and Activation of Cell Death Pathways in Type II Alveolar Epithelial Cells
30. Role of Oxidative Stress in Pulmonary Injury Induced by Nitrogen Mustard
31. Ozone Exacerbation of Acute Lung Injury Following Sepsis Is Associated with Oxidative and Nitrosative Stress
32. OA16.02 The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer
33. P28.02 Beyond PACIFIC: Outcomes and Toxicity According to Durvalumab Dosing Schedule Every 2 versus 4 Weeks
34. A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer
35. Segregation at a Locus Determining an Immunoglobulin Genetic Marker for the Light Chain Variable Region Affects Inheritance of Expression of an Idiotype
36. 2129P Feasibility of a virtual exercise program to mitigate decline in physical function for advanced lung cancer patients
37. LBA65 KRYSTAL-7: Efficacy and safety of adagrasib with pembrolizumab in patients with treatment-naïve, advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation
38. 1406P Outcomes of patients with metastatic EGFR mutant lung cancer requiring dose modifications of first line osimertinib
39. P89.03 Demonstrating VALUE of Liquid Biopsy for Lung Cancer in a Public Healthcare System
40. P21.05 Overall Survival by PD-L1 Status in Stage III NSCLC Following Implementation of Durvalumab: The Real-World Application of PACIFIC
41. 1247P Uptake of durvalumab in the management of stage III NSCLC: The real-world application of PACIFIC
42. 1195P The value of detecting resistance through liquid biopsy
43. Resident Macrophage Nitrogen Oxide Production Regulates Ozone Exacerbation of Acute Lung Injury Following Endotoxemia
44. Fusions NRG1 et adénocarcinomes pulmonaires : l’afatinib comme traitement potentiel
45. Sports for Athletes with Physical Disabilities
46. Ryanodine-Sensitive Calcium Flux Regulates Motility of Arbacia punctulata Sperm
47. REAL TIME MEASUREMENTS FROM LIVE SINGLE CELLS REVEAL THAT COMPONENTS OF THE MICROENVIRONMENT ALTER THE RADIUS OF DIFFUSION OF NITRIC OXIDE.
48. Overall survival (OS) from the AURA3 phase III study: Osimertinib vs platinum-pemetrexed (plt-pem) in patients (pts) with EGFR T790M advanced non-small cell lung cancer (NSCLC) and progression on a prior EGFR-tyrosine kinase inhibitor (TKI)
49. P1.01-40 EGFR ctDNA Detection: The Impact of Site of Progression and Burden of Progressive Disease
50. NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.